ICCC · Immucell Corp
United States · RS rating 90 · As of 2026-10-14
| Price | 10.75 USD |
|---|---|
| 1-day change | -0.4% |
| RS rating (overall / 1M / 3M / 12M) | 90 / 95 / 49 / 92 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 59 / 83 / 64 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | +167.7% |
| Sales growth Q/Q | +38.5% |
| Distance from 52-week high | +8.3% |
| Market cap (USD) | $72.4M |